ADVERTISEMENT

International

Recent Dose Miscalculating Experience In Canada

Canada’s shortage of children’s analgesic/antipyretic OTCs in 2022 as COVID-19 and seasonal flu virus combined to drive stockpiling by consumers. Some poison control centers and hospitals offered recommendations about modifying adult doses to pediatric use.

Supplement Firms Make Good Neighbors Knocking On State AGs’ Doors

“The first time we have a contact with them, if and when someone complains, is not because you're in trouble, but you already have a pre-existing relationship,” says former Maryland state AG Doug Gansler.

Gloomy Forecast For Cultivation Of Additional Hemp Legislation In Next Congress

“I think the Republican Congress is going to slow down all of what's called progress, for lack of a better word, toward having hemp be accessible to folks in all kinds of forms,” says Doug Gansler, former Maryland state AG and chair of Cadwalader, Wickersham & Taft LLP’s state AG practice.

FDA Checking Boxes On PREA Requirement Exposure For OTC Acetaminophen, Ibuprofen NDAs

Questions from researchers and public health advocates during workshop to discuss FDA authority under PREA Act point to agency and OTC NDA sponsors having additional boxes to check on potential unmet needs in drugs indicated for children and specifically on clarity of labeling for consumers of low health literacy, narrowing indications to prevent confusion and education about OTC drug formulations for health care providers.

Trump’s HHS Secretary Nominee Among Potential Political Pivots Pending For FDA

President-elect Trump’s nomination of Robert F. Kennedy Jr. as HHS secretary could be a focal point of change for FDA’s approach to Congress.

Beauty Product Launches: Vichy Anti-Dandruff Reaches US, Bain De Soleil Suncare Returns, More

Vichy Labs Dercos Anti-Dandruff Brand Makes Stateside Debut, targeted to 60% of Americans who don’t use dandruff-specific formulas, while Interparfums Inc. launches a proprietary fragrance line to sell in its first-ever boutiques and iconic Bain De Soleil suncare is slated to return to US stores under new ownership.

23andMe Cuts 40% Of Workforce, Discontinues Drug Development

23andMe cut 40% of its workforce and will discontinue its therapeutic program as part of ongoing restructuring. This comes after a data breach, series of layoffs and the resignation of its board members.

Vitaquest Floats Advantages For Chewable Supplements As Tide Rises For Gummies

“Many of our customers have been excited about it and decided to go that way. We just feel like, as gummies sort of take all the press, we might as well do our little part to say, ‘hey, look, there is a different way,’” says Terry Coyle, Vitaquest’s chief innovation officer.

Gummy Innovations: Island Abbey, TopGum, Extract Labs, Protein Candy And Mate & Me

‘World’s first’ from Protein Candy; Island Abbey latest gummies are filled; TopGum high-doses honey; Mate & Me’s him and her “fertility journey”; and Extract Labs offers organic gummy CBD ingredients, products.

MoCRA As Model? PCPC Touts Risk-Based Approach As Global Goal

“MoCRA confirms in many ways FDA’s adherence to a risk-based cosmetics regulatory framework, and in that way, it’s very positive,” says Francine Lamoriello, global strategies executive vice president at the Personal Care Products Council.